Root Financial Partners
ACRS icon

Root Financial Partners’s Aclaris Therapeutics ACRS Stock Holding History

Root Financial Partners’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$168 Buy
+32
New +$183 ﹤0.01% 3552
2026
Q2 		– Sell
-27
Closed -$101 – 441
2026
Q1 		$101 Buy
+27
New +$91 ﹤0.01% 3281

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Three Bridge Wealth Advisors
Three Bridge Wealth Advisors Los Altos, California $469M AUM 10.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Root Financial Partners's ACRS Position: Q3 2026 in Review

Root Financial Partners opened a new position in Aclaris Therapeutics (ACRS) in Q3 2026: 32 shares worth $168. The stake represents ﹤0.01% of the portfolio and ranks #3552 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ACRS as recently as Q1 2026.

Root Financial Partners first reported a position in ACRS in Q1 2026 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.

  • Root Financial Partners held 32 shares of Aclaris Therapeutics worth $168 as of Q3 2026.
  • Aclaris Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Aclaris Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3552 holding.
  • Root Financial Partners first reported a position in Aclaris Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.